NutriSystem (NASDAQ:NTRI) released its quarterly earnings results on Tuesday. The company reported $0.54 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.54, MarketWatch Earnings reports. The company had revenue of $159.30 million for the quarter, compared to analyst estimates of $164.18 million. NutriSystem had a net margin of 8.06% and a return on equity of 44.33%. The firm’s revenue was up .8% on a year-over-year basis. During the same period last year, the firm earned $0.49 earnings per share. NutriSystem updated its Q4 guidance to $0.58-0.63 EPS.
NTRI stock traded up $1.47 during mid-day trading on Thursday, hitting $37.03. The company had a trading volume of 13,527 shares, compared to its average volume of 866,335. The firm has a market cap of $982.25 million, a price-to-earnings ratio of 18.92, a P/E/G ratio of 1.62 and a beta of 1.27. NutriSystem has a 12 month low of $26.06 and a 12 month high of $55.10.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 19th. Shareholders of record on Friday, November 9th will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.70%. The ex-dividend date of this dividend is Thursday, November 8th. NutriSystem’s dividend payout ratio is 51.02%.
NutriSystem announced that its Board of Directors has approved a stock repurchase program on Tuesday, October 30th that authorizes the company to repurchase $75.00 million in outstanding shares. This repurchase authorization authorizes the company to reacquire up to 7.7% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board believes its stock is undervalued.
Several analysts have commented on the stock. DA Davidson lowered shares of NutriSystem from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $45.00 to $40.00 in a research report on Tuesday, July 31st. They noted that the move was a valuation call. Barrington Research raised shares of NutriSystem from a “market perform” rating to an “outperform” rating and set a $44.00 price objective on the stock in a research report on Thursday. ValuEngine raised shares of NutriSystem from a “strong sell” rating to a “sell” rating in a research report on Thursday. B. Riley lifted their price objective on shares of NutriSystem from $52.00 to $53.00 and gave the stock a “buy” rating in a research report on Tuesday, July 31st. Finally, Zacks Investment Research raised shares of NutriSystem from a “hold” rating to a “buy” rating and set a $45.00 price objective on the stock in a research report on Thursday, August 2nd. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $45.57.
NutriSystem Company Profile
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a D' kit that offers individuals with or at risk of type 2 diabetes.
Featured Story: Earnings Reports
Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.